One Novel Urinary Biomarkers of Acute Kidney Injury in Patients After Allogeneic Hematopoetic Stem Cell Transplantation
Transplantation Proceedings · 2024
DOI: 10.1016/j.transproceed.2024.04.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Aleksandra Kaszyńska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, Warsaw, Poland. Electronic address: aleksandra.kaszynska@wum.…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Biomarkers, Acute Kidney Injury, Glomerular Filtration Rate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Hematopoietic stem cell transplantation could be complicated by acute kidney injury and chronic kidney disease. It may be due to either previous chemotherapy or exposure to a variety of nephrotoxic drug or other causes. The aim of the study was to assess biomarkers of kidney injury in patients at least 3 months after hematopoetic stem cell transplantation (HSCT) under ambulatory care of the Hematology, Transplantation and Internal Medicine Department. We studied 80 prevalent patients after allogeneic HSCT and 32 healthy volunteers to obtain normal ranges of biomarkers. In this cross-sectional study we assessed retinol-binding protein 4 (RBP4), a biomarker of kidney injury in urine using commercially available assays. It was significantly higher in patients after HSCT when compared to healthy volunteers. When we divided patients according to kidney function (below and over 60 mL/min/1.72 m2), we found that the concentration of RBP4 was significantly higher in 23 patients with chronic kidney disease stage 3 compared to patients with estimated glomerular filtration (eGFR) over 60 mL/min/1.72 m2. In univariate correlations RBP4 was positively related to serum creatinine (r = 0.34, P < .01) and inversely to eGFR (r = -0.20, P < .05). Patients after allogeneic HSCT despite normal or near normal kidney function show evidence of kidney injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, Warsaw, Poland. Electronic address: aleksandra.kaszynska@wum.edu.pl.
- Department of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
- Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
- Department of Clinical Medicine, Medical University, Bialystok, Poland.
Zitieren
APA
Kaszyńska, A., Kępska-Dzilińska, M., Drożak, I., Karakulska-Prystupiuk, E., Tomaszewska, A., Basak, G. W., Żórawski, M., & Małyszko, J. (2024). One Novel Urinary Biomarkers of Acute Kidney Injury in Patients After Allogeneic Hematopoetic Stem Cell Transplantation. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.04.013
Vancouver
Kaszyńska A, Kępska-Dzilińska M, Drożak I, Karakulska-Prystupiuk E, Tomaszewska A, Basak GW, et al. One Novel Urinary Biomarkers of Acute Kidney Injury in Patients After Allogeneic Hematopoetic Stem Cell Transplantation. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.04.013
BibTeX
@article{Kaszyska2024,
author = {Kaszyńska, Aleksandra and Kępska-Dzilińska, Małgorzata and Drożak, Inga and Karakulska-Prystupiuk, Ewa and Tomaszewska, Agnieszka and Basak, Grzegorz Władysław and Żórawski, Marcin and Małyszko, Jolanta},
title = {One Novel Urinary Biomarkers of Acute Kidney Injury in Patients After Allogeneic Hematopoetic Stem Cell Transplantation},
journal = {Transplantation Proceedings},
year = {2024},
doi = {10.1016/j.transproceed.2024.04.013}
}
EUVIMED